Ashindoitiang John Adi, Canice Nwagbara Victor Ikechukwu, Ipeh Ugbem Theophilus, Owusu George Peter, Asuquo Maurice Efana
Department of Surgery, University of Calabar, University of Calabar Teaching Hospital, Calabar, Nigeria.
Department of Pathology, University of Calabar, University of Calabar Teaching Hospital, Calabar, Nigeria.
Rare Tumors. 2024 Feb 15;16:20363613241234243. doi: 10.1177/20363613241234243. eCollection 2024.
Dermatofibrosarcoma protuberans (DFSP) is an infrequent cutaneous tumour that may involve subcutaneous fat and in some cases fascia, muscles and bone. The infrequent occurrence lessens its clinical awareness in addition to its clinical semblance to many common cutaneous lesions. It is characterized by proclivity for local recurrence. We evaluated the clinical presentation and treatment outcomes of six consecutive cases of DFSP with histologic diagnosis in the University of Calabar Teaching Hospital, Calabar seen between January 2013 and December 2022. This was compared with total cutaneous malignances in the same period. The six consecutive patients comprised of two males and four females (M = F: 1:2) whose ages ranged from 21 to 57 years (mean of 36.5 years) and accounted for 7% of cutaneous malignancies. The site distribution was trunk (back) involved in 3 (50%) of the patients, limbs 3 (50%); upper 1 (17%) and lower limb 2 (33%). Clinical presentation was in the form of firm cutaneous mass with some ulcerated lesions that bled and some fungated. 50 percent of the patients presented with recurrent lesions and in all there was no regional lymphadenopathy or evidence of metastasis. There was a patient with Neurofibromatosis- 1 who had a huge fungated limb lesion offered amputation, four had wide local excision and one incision biopsy. Follow up was poor and the period ranged from 2 to 14 months (mean 7 months). Dermatofibrosarcoma protuberans is an uncommon tumour with clinical semblance to other cutaneous lesions. Early presentation, preoperative histologic diagnosis will enhance the goal of ensuring adequate excision. Adjuvant therapy with Imatinib with or without adjuvant radiotherapy are recommended in the treatment plan in view of the frequency of late presentation with advanced recurrent lesions and poor follow up.
隆突性皮肤纤维肉瘤(DFSP)是一种罕见的皮肤肿瘤,可累及皮下脂肪,在某些情况下还可累及筋膜、肌肉和骨骼。其罕见性加之在临床上与许多常见皮肤病变相似,降低了人们对它的临床认知。它的特点是易于局部复发。我们评估了2013年1月至2022年12月期间在卡拉巴尔大学教学医院卡拉巴尔分院连续收治的6例经组织学诊断的DFSP患者的临床表现和治疗结果,并与同期的所有皮肤恶性肿瘤进行了比较。这6例连续患者包括2名男性和4名女性(男:女 = 1:2),年龄在21至57岁之间(平均36.5岁),占皮肤恶性肿瘤的7%。部位分布为:躯干(背部)3例(50%),四肢3例(50%);上肢1例(17%),下肢2例(33%)。临床表现为质地硬的皮肤肿物,伴有一些溃疡、出血和呈蕈状的病变。50%的患者有复发病变,所有患者均无区域淋巴结肿大或转移迹象。有1例1型神经纤维瘤病患者因肢体有巨大蕈状病变而接受了截肢手术,4例接受了广泛局部切除,1例接受了切开活检。随访情况不佳,随访时间为2至14个月(平均7个月)。隆突性皮肤纤维肉瘤是一种罕见肿瘤,临床上与其他皮肤病变相似。早期就诊、术前组织学诊断将有助于实现充分切除的目标。鉴于晚期出现进展性复发病变的频率较高且随访不佳,在治疗方案中建议使用伊马替尼辅助治疗,可联合或不联合辅助放疗。